CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial...
Phase 2
Doylestown, Pennsylvania, United States and 9 other locations
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
Willow Grove, Pennsylvania, United States and 28 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Philadelphia, Pennsylvania, United States and 239 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Camden, New Jersey, United States and 202 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
Philadelphia, Pennsylvania, United States and 103 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Philadelphia, Pennsylvania, United States and 168 other locations
This phase II trial studies the effect of onapristone and anastrozole in treating patients with hormone receptor positive endometrial cancer...
Phase 2
Philadelphia, Pennsylvania, United States and 1 other location
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...
Phase 2
Philadelphia, Pennsylvania, United States and 16 other locations
in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), platinum-re ...
Phase 1
Philadelphia, Pennsylvania, United States and 17 other locations
This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...
Phase 1, Phase 2
Doylestown, Pennsylvania, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal